cdc-rfa-dp15-1511publication.pdf

Centers for Disease Control and Prevention

National Center for Chronic Disease Prevention and Health Promotion

Developing and Disseminating Programs to Build Sustainable Lupus Awareness, Knowledge, Skills and

Partnerships

CDC-RFA-DP15-1511

Application Due Date: 08/10/2015

Developing and Disseminating Programs to Build Sustainable Lupus Awareness, Knowledge, Skills and Partnerships

CDC-RFA-DP15-1511

TABLE OF CONTENTS

Part I. Overview Information

Federal Agency NameA.

Funding Opportunity TitleB.

Announcement TypeC.

Agency Funding Opportunity NumberD.

Catalog of Federal Domestic Assistance (CFDA) NumberE.

Dates F.

Executive Summary G.

Part II. Full Text

Funding Opportunity Description A.

Award Information B.

Eligibility Information C.

Required Registrations D.

Review and Selection Process E.

Award Administration Information F.

Agency Contacts G.

Other Information H.

Glossary I.

Part I. Overview Information Applicants must go to the synopsis page of this announcement at www.grants.gov and click on the "Send Me Change Notifications Emails" link to ensure they receive notifications of any changes to CDC-RFA-DP15-1511. Applicants also must provide an e-mail address to www.grants.gov to receive notifications of changes.

A. Federal Agency Name:

Centers for Disease Control and Prevention (CDC) B. Funding Opportunity Title:

Developing and Disseminating Programs to Build Sustainable Lupus Awareness, Knowledge, Skills and Partnerships C. Announcement Type: New - Type 1 This announcement is only for non-research domestic activities supported by CDC. If research is proposed, the application will not be considered Research for this purpose is defined at http://www.cdc. gov/od/ science/ integrity/ docs/cdc- policy- distinguishing- public- health-research- nonresearch. pdf.

D. Agency Funding Opportunity Number:

CDC-RFA-DP15-1511

E. Catalog of Federal Domestic Assistance (CFDA) Number:

93.068

93.328 93.135

F. Dates:

1. Due Date for Letter of Intent (LOI): 07/01/2015

2. Due Date for Applications: 08/10/2015, 11:59 p.m. U.S. Eastern Standard Time, at www.grants.gov.

3. Date for Informational Conference Call: 06/26/2015 Informational Conference Call Friday, June 26, 2015, 2pm ET Number: 866-758-6280 Participant Code: 35476725

G. Executive Summary:

1. Summary Paragraph:

This program is a new 5-year initiative to improve health outcomes and health-related quality of life among individuals with lupus. Eligible applicants include a variety of governmental and non-governmental organizations that have a clear mission to serve individuals with lupus and their care-givers through a network of affiliated programs. The new program has three components and will be implemented in the following phases: The first, during years 01 through 05 of the project period, the project will focus on component 1: creating sustainable lupus awareness and improve lupus-related health communications. Next, during years 01 through 05 of the project period, the project will focus on component 2:

developing a national network of lupus partnerships to ensure sustainability of awareness and programmatic strategies. Lastly, during years 03 through 05, the project will execute component 3: increasing patient and provider education and implementation of lupus self-management education, physical activity, and strength training strategies. This work will build upon and complement previous and current CDC efforts that include lupus registries, follow-up studies, formative research, and creating a public health agenda. The impact of the program will be to improve lupus symptom recognition, diagnosis, and use of self-management resources; improve lupus health outcomes; and improve health-related quality of life among individuals with lupus.

a. Eligible Applicants: Open Competition

b. FOA Type: Cooperative Agreement

c. Approximate Number of Awards: 2

d. Total Project Period Funding: $18,500,000

e. Average One Year Award Amount: $2,500,000

f. Number of Years of Award: 5

g. Estimated Award Date: 09/30/2015

h. Cost Sharing and / or Matching Requirements: N Cost sharing or matching funds are not required for this program. Although no statutory matching requirement for this FOA exists, leveraging other resources and related ongoing efforts to promote sustainability is strongly encouraged.

Part II. Full Text A. Funding Opportunity Description

Additional CFDA Number:

https://foa.grantsolutions.gov/announcementmodule/www.grants.gov https://foa.grantsolutions.gov/announcementmodule/www.grants.gov http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf http://www.grants.gov

Additional CFDA Number:

1. Background

a. Overview

Systemic Lupus Erythematosus (SLE) is an autoimmune disease in which the immune system produces antibodies to cells within the body leading to widespread inflammation and tissue damage. SLE may be characterized by periods of illness with a variety of clinical manifestations, that can affect joints, skin, brain, lungs, kidneys, and blood vessels, and periods of remission. People with SLE may experience fatigue, pain or swelling in joints, skin rashes, and fevers. SLE can occur at any age, but is primarily a disease of young women with peak occurrence between puberty and child-bearing years. It has strong disparities in incidence, prevalence, and survival by both sex and race/ethnicity, with women affected 8 times more than men and many minorities affected at higher rates than whites. Estimates of the prevalence of SLE vary widely, and misdiagnosis is common.

Newer and more complete CDC-funded population-based SLE registries with a primary purpose of generating better prevalence (and incidence) estimates published results in 2014. Annual prevalence from 2002-2004 were much higher for blacks than whites in Michigan (Washtenaw and Wayne Counties) (111.6 vs 47.5 per 100,000 persons) and in Georgia (DeKalb and Fulton Counties) (128.0 vs. 39.9 per 100,000 persons). Annual prevalence from 2007-2009 for American Indians/Alaska Natives was 178 per 100,000. New registries in California (San Francisco County) and New York City (Manhattan) will soon provide annual prevalence estimates for Hispanics and Asians.

Annual prevalence estimates were much higher among women than men in Michigan (9.3 vs 1.5 per 100,000 persons), in Georgia (145.8 vs 17.5 per 100,000 persons), and in the American Indian/Alaska Native population (271 vs. 54 per 100,000 persons).

b. Statutory Authorities

This program is authorized under sections 301 [42 U.S.C. 241], 317 (k)(2), and 317C of the Public Health Service Act, [42 U.S.C. Sections 247b (k)(2) and 247b-4] as amended.

c. Healthy People 2020

This FOA addresses Healthy People 2020. It is committed to the vision of a society in which all people live long, healthy lives. This cooperative agreement addresses Healthy People 2020 focus areas of Arthritis, Osteoporosis, and Chronic Back Conditions; Access to Health Services, Disability, and Health; Health Communication and Health Information Technology; and Health-related Quality of Life & Well-being. All arthritis objectives are relevant because lupus is considered part of “doctor-diagnosed arthritis” as used in Healthy People and in CDC surveillance systems.

This site is available at http://healthypeople.gov.

d. Other National Public Health Priorities and Strategies

This Funding Opportunity Announcement aligns with national health objectives aimed at creating social and physical environments that promote good health for all with the following goals of CDC’s National Center for Chronic Disease Prevention and Health Promotion.

Monitor, prevent, delay, detect, and control chronic diseases;

Conduct chronic disease research and translate to practical and effective prevention strategies;

Promote social, environmental, policy, and systems approaches that support health;

Achieve equity in health by eliminating racial and ethnic disparities and achieving optimal health for all Americans;

Work with partners from all sectors of society to increase the reach and effectiveness of public health programs; and as outlined in the following national plans: and guidelines:

The Guide to Community Preventive Services: http://www.thecommunityguide.org/index.html;

The National Prevention Strategy: http://www.surgeongeneral.gov/initiatives/prevention/strategy/report.pdf;

National Physical Activity Plan: http://www.physicalactivityplan.org;

Dietary Guidelines for Americans, 2010: http://www.cnpp.usda.gov/DGAs2010-PolicyDocument.htm;

2008 Physical Activity Guidelines for Americans: http://www.health.gov/PAGuidelines/;

School Health Guidelines to Promote Healthy Eating and Physical Activity:http://www.cdc.gov/mmwr/pdf/rr/rr6005.pdf

e. Relevant Work

CDC has previously funded and is currently funding work on a variety of SLE-relevant activities, including lupus registries, follow-up studies, formative research, and creating a public health agenda (currently under development).

Five Lupus Registries were designed to create credible estimates of the incidence and prevalence of lupus in various ethnic groups by creating population-based cohorts. These include:

• Developing and Implementing the Georgia Lupus Registry

• Michigan Lupus Epidemiology and Surveillance (MILES) Program

• California Lupus Surveillance Program

• Manhattan Lupus Surveillance Program

• Indian Health Service Lupus Project Three longitudinal follow-up studies of established population-based lupus cohorts will determine natural history, access to care, current treatment, and other outcomes. These currently funded projects are being completed by University of Michigan, Emory University, and University of California, San Francisco.

Formative research on SLE self-management is being completed through a two-year (beginning in 2014) Interagency Agreement with Oak Ridge Associated Universities titled “Filling a Gap: Creating Educational Program/Tools/Materials to Enhance Self-Management in Systemic Lupus Erythematosus (SLE).”

http://healthypeople.gov/ http://www.surgeongeneral.gov/initiatives/prevention/strategy/report.pdf http://www.health.gov/PAGuidelines/

A National Public Health Agenda for Lupus will help prioritize public health efforts addressing lupus. This is being done through the National Association of Chronic Disease Directors award “Developing a Public Health Agenda for Lupus”, an activity that will be completed in Fall 2015.

2. CDC Project Description

a. Approach

Goal: Developing and Disseminating Programs to Build Sustainable Lupus Awareness, Knowledge, Skills, and Partnerships

Strategy Activities Short Term Outcomes Medium Term Outcomes Long Term Outcomes (Impacts)

Create sustainable lupus awareness and improve lupus-related health communications

Conduct and evaluate public awareness campaigns for recently diagnosed individuals with lupus, primary care providers, and lupus specialists (rheumatologists) Implement and evaluate educational programs for specific groups (e.g., young African American women) Provide informational resources for the general public, people with lupus, and caregivers

Increase awareness among providers and individuals about how to recognize signs and symptoms of lupus

Increase understanding among providers and individuals about what to do if lupus is suspected

Reduce the length of time from lupus symptom recognition to diagnosis

Increased knowledge and decreasing misinformation about lupus

Reduced stigma

Reduction in serious complications of untreated lupus

Decrease missed work days for persons with lupus

Improved lupus health outcomes

Improved health-related quality of life among individuals with lupus

Develop a national network of lupus partnerships

Engage appropriate lupus-affiliated organizations and others who can support lupus network goals and activities Conduct outreach to primary care providers and others who need to learn to diagnose lupus more quickly

Develop a sustainable partnership network

Partners support awareness and communication efforts

Increase use of and referral to lupus clinical and community resources

Increased awareness and use of evidence based tool(s) for self-management, physical activity, and strength training

Quicker diagnoses

Earlier entry into treatment

Increase patient and provider education and implementation of lupus self-management education, physical activity, and strength training strategies

Develop and evaluate evidence-based lupus self-management resources (informed by the ORAU/ORISE Gap Analysis) Develop and disseminate resources related to:

promoting and sustaining lupus self-management after diagnosis promoting and sustaining physical activity and strength training interventions for individuals with lupus after diagnosis

Increase awareness and use of evidence based tool(s) for:

- self-management of lupus and related co-morbidities

- physical activity and strength training

Increase lupus patient education about physical activities that incorporate strength training

Increase self-management skills including medication adherence and co-morbidity management

Increased physical activity and strength training among patients with lupus

i. Purpose

The purpose of this program is to conduct activities that enhance the health and quality of life of people with lupus and their care givers by creating sustainable lupus awareness and improving lupus-related health communications, increasing patient and provider education and implementation of lupus self-management education, physical activity, and strength training strategies, and developing national partnerships with community-based organizations to enhance sustainability of efforts to increase awareness, improve health communication, and increase referral and dissemination of self-management and physical activity resources.

ii. Outcomes

Recipients of this award are expected to demonstrate measurable progress toward addressing short-term outcomes depicted in the logic model (see Approach).

Component 1

Increase awareness among providers and individuals about how to recognize signs and symptoms of lupus.

Increase understanding among providers and individuals about what to do if lupus is suspected.

Component 2 Develop a sustainable partnership network.

Partners support awareness and communication efforts.

Increase use of and referral to lupus clinical and community resources.

Increased awareness and use of evidence-based tool(s) for self-management, physical activity, and strength training.

Component 3 Increase awareness and use of evidence based tool(s) for:

Self-management of lupus and related co-morbidities.

Physical activity and strength training.

Increase lupus patient education about physical activities that incorporate strength training.

Medium and long-term outcomes: The awardee will work collaboratively with CDC to reduce length of time from lupus symptom recognition to diagnosis, reduce stigma by increasing knowledge and decreasing misinformation about lupus, decrease missed work days for persons with lupus, increase self-management skills, increase lupus patient education about physical activities that incorporate strength training, and increase physical activity and strength training among persons with lupus.

iii. Strategies and Activities

The awardees of CDC-FOA-DP15-1511 will work collaboratively with CDC and other stakeholders to implement strategies and activities to improve health and reduce the impact of lupus on individuals and their care givers by using a combination of evidence-based, practice-based, or expert-informed approaches. The activities outlined in the program logic model are designed to address lupus through population-based strategies that should lead to measurable health improvements.

Component 1: Create sustainable lupus awareness and improve lupus-related health communications (This component will be conducted during project years 01 through 05).

Conduct targeted health communications campaigns for recently diagnosed individuals with SLE, primary care providers, and lupus specialists, based on research findings to date from the DOE/ORISE project, “Filling a Gap: Creating Educational Program/Tools/Materials to Enhance Self-Management in Systematic Lupus Erythematosus (SLE)” funded by CDC.

Develop and execute evidence-based communications strategies based on research findings Develop or expand a sustained multifaceted media relations outreach program Leverage in-kind and earned media to maximize reach of awareness campaign Conduct outreach to the public and patients via dissemination of campaign materials, engaging media with public service announcements and other means Work with an established group (such as the expert panel for the National Public Health Agenda for Lupus) to coordinate outreach activities Awareness campaign activities may include:

o Distributing campaign materials to priority audiences through effective channels as identified by available research findings o Developing and publishing print and/or electronic materials for parents of newly diagnosed teens with SLE o Developing, updating, or reprinting appropriate materials o Providing CME training regarding lupus for providers o Providing public service announcements, advertisements in medical journals and parent’s magazines encouraging referrals to specialists for appropriate symptoms; and o Using baseline survey data for selected target groups to measure campaign coverage

Component 2: Develop a national network of lupus partnerships. (This component will be conducted during project years 01 through 05).

Strengthen a sustainable partnership network of lupus-affiliated organizations to provide local support of awareness and health communications efforts Support a national network of local, state, and national organizations to promote the goals of this cooperative agreement Work with local, regional and state affiliates and chapters and other health-related organizations to facilitate local public health activities for people with lupus in partnership with state and local government agencies Conduct outreach to primary care providers, professional association and others who can help diagnose lupus more quickly Work with health-related organizations (such as those represented in developing A National Public Health Agenda for Lupus) to facilitate public health activities, such as:

o Facilitate problem solving and idea sharing among organizations involved in collaborative activities, including supporting and expanding communication vehicles (i.e., social media, list management tools, web sites, newsletters, conference calls, meetings) to strengthen programs promoting public awareness of lupus, and to provide education for those with lupus, the general public, and for health care providers. Describe partner and community engagement throughout the project period, including the involvement of health care providers. Describe partner and community engagement throughout the project period, including the involvement of described in the attached logic model:

(1) The number of people with doctor-diagnosed SLE will increase their participation in self-management activities that will prolong their quality of life and delay progression of SLE and increase co-morbidity management.

(2) The number of people with doctor-diagnosed SLE will increase their participation in physical activity and strength training activities. These activities are known to increase lower extremity muscle mass and improve quality of life.

(3) There will be an increase in the number of physicians providing SLE self-management and physical activity information to doctor-diagnosed patients.

(4) There will be an increase in the number of physicians and people with probable SLE diagnoses that recognize the signs and symptoms of SLE.

Component 3: Increase patient and provider education and implementation of lupus self-management education, physical activity, and strength training strategies. (This component will be conducted during project years 03 through 05).

• Develop and evaluate evidence-based lupus self-management resources

• Develop and disseminate resources to promote and sustain physical activity, strength training, and weight management interventions after diagnosis.

• Implement and evaluate strategies to disseminate existing and new educational materials and tools to those with lupus that are under served.

• Support development of strategies that empower individuals to manage their health and health care (e.g., increase or strengthen community-clinical links and resources to support self-management education, promote use of culturally competent standardized education materials).

• Conduct outreach to healthcare practitioners, provider institutions, and state and local health departments to link persons with lupus to community resources.

Program/Epidemiological Objectives:

(1) From FY 2015 to FY 2020, people with doctor-diagnosed SLE and their care givers will increase their knowledge and use of self-management, physical activity, and strength training techniques resulting in improved actions and health-related quality of life.

1.Collaborations

a. With CDC-funded programs:

The awardees of CDC-FOA-DP15-1511 are strongly recommended to work collaboratively with CDC and CDC-funded projects including previously funded lupus registries projects, current lupus follow-up studies and formative research projects in order to maximize use of limited federal resources.

b. With organizations external to CDC:

The awardees of CDC-FOA-DP15-1511 are also strongly recommended to work collaboratively with participants and supporters of the National Public Health Agenda for Lupus, such as the National Association of Chronic Disease Directors, Lupus Foundation of America, state and local health departments, and others in order to maximize the potential for greater success of conducting activities that will enhance the health and quality of life of people with lupus.

2. Target Populations

Applicants must target individuals with lupus, specifically those with systemic lupus erythematosus (SLE) and sub populations of individuals with SLE where health disparities are evident. They must also with work health care providers who care for patients with SLE.

a. Inclusion

Applicants must describe the ways in which the efforts of this FOA will include individuals with lupus and their care providers in the planning, development, and implementation of proposed activities.

iv. Funding Strategy (for multi-component FOAs only)

For this FOA, there will be up to two awardees for all components. Organizations will only need to submit one application under this FOA, addressing all three components.

b. Evaluation and Performance Measurement

i. CDC Evaluation and Performance Measurement Strategy

With technical assistance from CDC staff, the grantee will design an evaluation plan based on current data sources available (i.e., current rheumatologist and current information being provided to help SLE patients manage their disease outside of the clinic arena). The lupus registries projects and follow-up studies will provide a baseline for provider information and will expand to create data sources as necessary.

The grantee will determine the best evaluation plan (seeking CDC guidance as necessary) that measures the following program goals (Impact Evaluation) based on the short, medium, and long-term goals.

ii. Applicant Evaluation and Performance Measurement Plan

CDC may revise the existing requirements through an addendum to this notice or through updated guidance for continuation awards, which could include additional recipient requirements for evaluation and performance measurement and may require additional government clearances under the Paperwork Reduction Act. Any additional reporting requirements will not exceed applicable grants regulation limits. The Applicant Evaluation and Performance Measurement Plan will be comprised of two components:

1. Tracking progress and completion of strategies - Awardees will track overall progress on infrastructure and short-term outcome objectives, as well as specific progress on activities on a quarterly basis. This collection of data is known as performance monitoring data.

Use of ongoing performance monitoring data, along with any needs assessment or other data, for ongoing program improvement and mid-course corrections.

Track overall progress on outcome objectives as well as specific progress on activities designed for targeted populations. Use of performance monitoring data and other available sources to document the steps taken to implement program activities by describing successes, barriers, and challenges.

2. Measurement of short-term outcomes - With guidance as requested from CDC, awardees will set targets and then monitor progress towards these targets on the number of individuals with lupus and providers who were reached by the awareness campaign, the number of evidence-based self-management, physical activity, and strength programs that were disseminated, and the number of referrals to lupus clinical and community based resources.

c. Organizational Capacity of Awardees to Execute the Approach

Funding will be provided to the qualified applicant who can demonstrate previous experience and success in serving the diverse needs of individuals with SLE and their families in the U.S. Examples of organizational capacity criteria for applicants include:

Serving as an organization wholly dedicated to lupus with national and local legally affiliated networks (legal authority to conduct work under the name of the national organization), accountable under a series of approved criteria and standards with robust quality assurance. In order for this program to have nationwide impact, the organization should be able to disseminate strategies to at least 25 states. Applicants must include a signed letter of support from each affiliated program participating in this initiative. Letters of support can be included in the appendix section of the application.

Providing direct support services for people with lupus through professional health educators and a legally affiliated network (legal authority to conduct work under the name of the national organization).

Successful history of conceiving developing and carrying out national lupus awareness campaigns such as advertising council campaigns and the organizational capacity to handle increased inquiries by phone and web.

Experience in surveying, identifying, and interpreting the needs of those who are affected by SLE.

Experience in identifying the needs of those who have or may have lupus in translating those needs into messages that resonate with the target audience and motivate action.

Capacity and proven prior success to engage various types of media across the country to use campaign and/or health communication materials.

Proven prior success distributing and promoting awareness and/or health communication campaigns on behalf of non-profit organizations and government agencies.

Capacity to engage volunteer talent from the advertising and communication industries and the resources of the business and lupus communities to deliver critical messages to the public

In addition, applicants for all three components of this FOA must be able to demonstrate the capacity to conduct all of the strategies and activities outlined in this FOA (i.e., create sustainable lupus awareness and improve lupus-related health communications, increase patient and provider education and implementation of lupus self-management education, physical activity, and strength training strategies, and develop a national network of lupus partnerships.

d. Work Plan

Applicants must submit a detailed work plan for year 01 and provide a general summary of work plan activities for years 02-05 in narrative form.

The work plan for year 01 must describe the process by which the awardee will review and update work plan activities for years 02-05 according to the key public health priorities within the national public health agenda for lupus (expected to be released by Fall 2015). The work plan should align with the logic model and describe how the applicant plans to implement all of the required activities to achieve FOA outcomes. The work plan should not exceed 25 pages.

The work plan must, at a minimum, include:

Activities and timelines to support achievement of FOA outcomes. These activities must be aligned with the FOA logic model and should have appropriate performance measures or milestones for accompanying tasks.

Staff and administrative roles and functions to support implementation of the award. Specify management and leadership positions and qualifications for those roles.

Administration and assessment processed to ensure successful implementation and quality assurance.

SMART Objectives (i.e., Specific, Measurable, Achievable, Relevant, Time-framed) for each proposed strategy, including objective description, baseline and target information, target population, estimated number of people reached, and evaluation plan.

See sample work plan below for an example framework:

Expected Outcome(s) for the Project Period

Activity/ Strategy Performance Measure(s)

Data Source (s)

Person Responsible

Timeframe Activity Completion

Date

Expected Outcome(s) for the Project Period

Activity/ Strategy Performance Measure(s)

Data Source (s) Person Responsible

Timeframe Activity Completion Date

e. CDC Monitoring and Accountability Approach Monitoring activities include routine and ongoing communication between CDC and awardees, site visits, and awardee reporting (including work plans, performance, and financial reporting). Consistent with applicable grants regulations and policies, CDC expects the following to be included in post-award monitoring for grants and cooperative agreements:

Tracking awardee progress in achieving the desired outcomes.

Ensuring the adequacy of awardee systems that underlie and generate data reports.

Creating an environment that fosters integrity in program performance and results.

Monitoring may also include the following activities:

Ensuring that work plans are feasible based on the budget and consistent with the intent of the award.

Ensuring that awardees are performing at a sufficient level to achieve outcomes within stated timeframes.

Working with awardees on adjusting the work plan based on achievement of outcomes, evaluation results and changing budgets.

Monitoring performance measures (both programmatic and financial) to assure satisfactory performance levels.

Other activities deemed necessary to monitor the award, if applicable.

These activities may include monitoring and reporting activities that assist grants management staff (e.g., grants management officers and specialists, and project officers) in the identification, notification, and management of high-risk grantees.

Ensuring the adequacy of systems that underlie and generate data and reports;

Ensuring that awardee work plan is feasible, fiscally responsible, consistent with the intent of the award, and have acceptable milestones and timelines;

Ensuring that awardee is conducting activities outlined in the FOA/Logic Model on a routine basis (e.g., data collection and analysis, evaluation and dissemination of innovative practices, partnership engagement, etc.)

Adjusting work plan activities based on achieving objectives and/or budget changes;

Communicating as needed, or at minimum monthly, with the project coordinator and the project officer on conference calls;

Participating in webinars and meetings; and Providing tools/resources aligned with program activities and FOA outcomes; and assessment and implementation support.

f. CDC Program Support to Awardees (THIS SECTION APPLIES ONLY TO COOPERATIVE AGREEMENTS)

Technical Assistance:

Provide pre-application assistance to potential applicants Provide post award technical assistance Provide subject matter expertise regarding strategies and activities Facilitate collaborative opportunities with national partners

Provide resources and tools necessary for the successful implementation of strategies and activities to meet project goals Information sharing

Facilitate routine conference calls, webinars, and information exchange among awardees and lupus and public health stakeholders Develop mechanism for documenting and sharing lessons learned

B. Award Information

1. Funding Instrument Type: Cooperative Agreement CDC's substantial involvement in this program appears in the CDC Program Support to Awardees

Section.

2. Award Mechanism:

3. Fiscal Year: 2015 Estimated Total Funding: $2,500,000

4. Approximate Total Fiscal Year Funding: $4,000,000

5. Approximate Project Period Funding: $18,500,000

6. Total Project Period Length: 5 year(s)

7. Expected Number of Awards: 2

8. Approximate Average Award: $2,500,000 Per Project Period

9. Award Ceiling: $4,000,000 Per Project Period

10. Award Floor: None

11. Estimated Award Date: 09/30/2015 Throughout the project period, CDC will continue the award based on the availability of funds, the evidence of satisfactory progress by the awardee (as documented in required reports), and the determination that continued funding is in the best interest of the federal government. The total number of years for which federal support has been approved (project period) will be shown in the “Notice of Award.” This information does not constitute a commitment by the federal government to fund the entire period. The total project period comprises the initial competitive segment and any subsequent non-competitive continuation award(s).

12. Budget Period Length: 12 month(s)

13. Direct Assistance Direct Assistance (DA) is not available through this FOA.

C. Eligibility Information

1. Eligible Applicants Eligibility Category: State governments

County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits without 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification) Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Government Organizations:

State (includes the District of Columbia) Local governments or their bona fide agents Territorial governments or their bona fide agents in the Commonwealth of Puerto Rico, the Virgin

Territorial governments or their bona fide agents in the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau.

State controlled institutions of higher education American Indian or Alaska Native tribal governments (federally recognized or state-recognized)

Non-government Organizations:

American Indian or Alaska native tribally designated organizations

Other:

Private colleges and universities Community-based organizations Faith-based organizations

2. Additional Information on Eligibility N/A

The award ceiling for this FOA is $4,000,000. CDC will consider any application requesting an award higher than this amount as non-responsive and it will receive no further review. If a pre-application is required, then specify here and include it in the special eligibility requirements section. (http:// www.hhs.gov/ asfr/ ogapa/ aboutog/ hhsgps107.pdf)

3. Justification for Less than Maximum Competition

N/A

4. Cost Sharing or Matching Cost Sharing / Matching Requirement:

No

Cost sharing or matching funds are not required for this program. Although no statutory matching requirement for this FOA exists, leveraging other resources and related ongoing efforts to promote sustainability is strongly encouraged.

5. Maintenance of Effort

Maintenance of effort is not required for this program.

D. Required Registrations

Additional materials that may be helpful to applicants: http://www.cdc.gov/od/pgo/funding/docs/Financial ReferenceGuide.pdf.

1. Required Registrations An organization must be registered at the three following locations before it can submit an application for funding at www.grants.gov.

a. Data Universal Numbering System: All applicant organizations must obtain a Data Universal Numbering System (DUNS) number. A DUNS number is a unique nine-digit identification number provided by Dun & Bradstreet (D&B). It will be used as the Universal Identifier when applying for federal awards or cooperative agreements.

The applicant organization may request a DUNS number by telephone at 1-866-705-5711 (toll free) or Internet at http:// fedgov.dnb.com/webform/displayHomePage.do. The DUNS number will be provided at no charge.If funds are awarded to an applicant organization that includes sub-awardees, those sub-awardees must provide their DUNS numbers before accepting any funds.

b. System for Award Management (SAM): The SAM is the primary registrant database for the federal government and the repository into which an entity must submit information required to conduct business as an awardee. All applicant organizations must register with SAM, and will be assigned a SAM number. All information relevant to the SAM number must be current at all times during which the applicant has an application under consideration for funding by CDC. If an award is made, the SAM information must be maintained until a final financial report is submitted or the final payment is received, whichever is later. The SAM registration process usually requires not more than five business days, and registration must be renewed annually. Additional information about registration procedures may be found at www.SAM.gov.

c. Grants.gov: The first step in submitting an application online is registering your organization through www.grants.gov, the official HHS E-grant website. Registration information is located at the "Get Registered" option at www.grants.gov.

All applicant organizations must register with www.grants.gov. The one-time registration process usually takes not more than five days to complete. Applicants must start the registration process as early as possible.

2. Request Application Package http://www.hhs.gov/asfr/ogapa/aboutog/hhsgps107.pdf http://www.cdc.gov/od/pgo/funding/docs/FinancialReferenceGuide.pdf http://www.grants.gov http://fedgov.dnb.com/webform/displayHomePage.do http://fedgov.dnb.com/webform/displayHomePage.do https://www.SAM.gov http://www.Grants.gov http://www.grants.gov

2. Request Application Package Applicants may access the application package at www.grants.gov.

3. Application Package Applicants must download the SF-424, Application for Federal Assistance, package associated with this funding opportunity at www.grants.gov.

If Internet access is not available, or if the online forms cannot be accessed, applicants may call the CDC PGO staff at 770-488-2700 or e-mail PGO PGOTIM@cdc.gov for assistance. Persons with hearing loss may access CDC telecommunications at TTY 1-888-232-6348.

4. Submission Dates and Times If the application is not submitted by the deadline published in the FOA, it will not be processed. PGO personnel will notify the applicant that their application did not meet the deadline. The applicant must receive pre-approval to submit a paper application (see Other Submission Requirements section for additional details). If the applicant is authorized to submit a paper application, it must be received by the deadline provided by PGO.

a. Letter of Intent Deadline (must be emailed or postmarked by) Due Date for Letter of Intent: 07/01/2015

b. Application Deadline Due Date for Applications: 08/10/2015, 11:59 p.m. U.S. Eastern Standard Time, at www.grants.gov. If Grants.gov is inoperable and cannot receive applications, and circumstances preclude advance notification of an extension, then applications must be submitted by the first business day on which grants.gov operations resume.

Date for Informational Conference Call: 06/26/2015

Informational Conference Call Friday, June 26, 2015, 2pm ET Number: 866-758-6280 Participant Code: 35476725

5. CDC Assurances and Certifications All applicants are required to sign and submit “Assurances and Certifications” documents indicated at http://www.cdc.gov/grants/interestedinapplying/applicationprocess.html.

Complete the applicable assurances and certifications on an annual basis, name the file “Assurances and Certifications” and upload it as a PDF file at www.grants.gov Complete the applicable assurances and certifications and submit them directly to CDC on an annual basis at http://wwwn.cdc.

gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/ Homepage.aspx Assurances and certifications submitted directly to CDC will be kept on file for one year and will apply to all applications submitted to CDC by the applicant within one year of the submission date.

6. Content and Form of Application Submission Applicants are required to include all of the following documents with their application package at www.grants.gov.

7. Letter of Intent

A Letter of Intent (LOI) is strongly encouraged. The purpose of this LOI is to allow CDC program staff to estimate the number of and plan for the review of submitted applications.

LOI should be sent via U.S. express mail, delivery service, or email by July 1, 2015 to:

Casey Hannan CDC, National Centers for Chronic Disease Prevention and Health Promotion (NCCDPHP) Division of Population Health 4770 Buford Hwy. NE MS F-78 Atlanta, GA 30341 Telephone number: 770-488-6211 Email address: CLH8@cdc.gov

8. Table of Contents (No page limit and not included in Project Narrative limit): The applicant must provide, as a separate attachment, the “Table of Contents” for the entire submission package.

Provide a detailed table of contents for the entire submission package that includes all of the documents in the application and headings in the "Project Narrative" section. Name the file "Table of Contents" and upload it as a PDF file under "Other Attachment Forms" at www.grants.gov.

9. Project Abstract Summary (Maximum 1 page) A project abstract is included on the mandatory documents list and must be submitted at www.grants.gov. The project abstract must be a self-contained, brief summary of the proposed project including the purpose and outcomes. This summary must not include any proprietary or confidential information. Applicants must enter the summary in the "Project Abstract Summary" text box at www.grants.gov.

http://www.grants.gov http://www.grants.gov https://foa.grantsolutions.gov/announcementmodule/PGOTIM@cdc.gov%20 http://www.grants.gov http://www.cdc.gov/grants/interestedinapplying/applicationprocess.html http://www.grants.gov/ http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx http://www.grants.gov mailto:CLH8@cdc.gov http://www.grants.gov

10. Project Narrative (Maximum of 20 pages, single spaced, Calibri 12 point, 1-inch margins, number all pages. Content beyond 20 pages will not be considered. The 20 page limit includes the work plan. For a multi-component FOA, maximum page limit is 25.)

The Project Narrative must include all of the bolded headings shown in this section. The Project Narrative must be succinct, self-explanatory, and in the order outlined in this section. It must address outcomes and activities to be conducted over the entire project period as identified in the CDC Project Description section. Applicants must submit a Project Narrative with the application forms. Applicants must name this file “Project Narrative” and upload it at www.grants.gov.

a. Background Applicants must provide a description of relevant background information that includes the context of the problem (See CDC Background).

b. Approach

i. Purpose Applicants must describe in 2-3 sentences specifically how their application will address the problem as described in the CDC Background section.

ii. Outcomes Applicants must clearly identify the outcomes they expect to achieve by the end of the project period. Outcomes are the results that the program intends to achieve. All outcomes must indicate the intended direction of change (e.g., increase, decrease, maintain). (See the logic model in the Approach section of the CDC Project Description.)

iii. Strategies and Activities Applicants must provide a clear and concise description of the strategies and activities they will use to achieve the project period outcomes.

Applicants must select existing evidence-based strategies that meet their needs, or describe in the Applicant Evaluation and Performance Measurement Plan, how these strategies will be evaluated over the course of the project period. (See CDC Project Description: Strategies and Activities section.)

1. Collaborations Applicants must describe how they will collaborate with programs and organizations either internal or external to CDC.

2. Target Populations Applicants must describe the specific target population(s) in their jurisdiction and explain how such a target will achieve the goals of the award and/or alleviate health disparities. Refer back to the CDC Project Description section – Approach: Target Population.

c. Applicant Evaluation and Performance Measurement Plan Applicants must provide an overall evaluation and performance measurement plan that is consistent with the CDC Evaluation and Performance Measurement Strategy section of the CDC Project Description of this FOA. Data collected must be used for ongoing monitoring of the award to evaluate its effectiveness, and for continuous program improvement.

The plan must:

Affirm the ability to collect the performance measures and respond to the evaluation questions specified in the CDC strategy. (For guidance regarding the Paperwork Reduction Act, please visit http://www.hhs.gov/ocio/policy/collection/infocollectfaq.html) Describe how key program partners will participate in the evaluation and performance measurement planning processes.

Describe how evaluation findings will be used for continuous program quality improvement.

Where the applicant chooses to, or is expected to, take on specific evaluation studies:

Describe the type of evaluation(s) (i.e., process, outcome, or both) to be conducted.

Describe key evaluation questions to be addressed by these evaluations.

Describe other information relevant to the evaluation (e.g., measures, data sources)

Describe other information, as determined by the CDC program (e.g., performance measures to be developed by the applicant) that must be included.

Describe potentially available data sources and feasibility of collecting appropriate evaluation and performance data.

Describe how evaluation and performance measurement will contribute to development of that evidence base, where program strategies are being employed that lack a strong evidence base of effectiveness.

Awardees will be required to submit a more detailed evaluation and performance measurement plan within the first 6 months of the project, as outlined in the reporting section of the FOA.

d. Organizational Capacity of Applicants to Implement the Approach Applicant must address the organizational capacity requirements as described in the CDC Project Description.

http://www.hhs.gov/ocio/policy/collection/infocollectfaq.html

Serving as an organization with documented experience serving the needs of people with lupus with a national legally affiliated network (legal authority to conduct work under the name of the national organization), accountable under a series of approved criteria and standards with robust quality assurance. In order for this program to have nationwide impact, the organization should be able to disseminate strategies to at least 25 states.

Providing direct support services for people with lupus through professional health educators and a legally affiliated network (legal authority to conduct work under the name of the national organization).

Successful history of conceiving developing and carrying out national lupus awareness campaigns such as advertising council campaigns and the organizational capacity to handle increased inquiries by phone and web.

Experience in surveying, identifying, and interpreting the needs of those who are affected by SLE.

Experience in identifying the needs of those who have or may have lupus in translating those needs into messages that resonate with the target audience and motivate action.

Capacity and proven prior success to engage various types of media across the country o use campaign and/or health communication materials.

Proven prior success distributing and promoting awareness and/or health communication campaigns on behalf of non-profit organizations and government agencies.

Capacity to engage volunteer talent from the advertising and communication industries and the resources of the business and lupus communities to deliver critical messages to the public.

11. Work Plan (Included in the Project Narrative’s 20 page limit) Applicants must prepare a work plan consistent with the CDC Project Description Work Plan section. The work plan integrates and delineates more specifically how the awardee plans to carry out achieving the project period outcomes, strategies and activities, evaluation and performance measurement.

Applicants must name this file "Work Plan" and upload it as a PDF file at www.grants.gov.

12. Budget Narrative Applicants must submit an itemized budget narrative, which may be scored as part of the Organizational Capacity of Awardees to Execute the Approach.